New report reveals lack of awareness on illegal tobacco market in Europe

Nov.22.2022
New report reveals lack of awareness on illegal tobacco market in Europe
New report shows only 14% of Europeans aware of $10bn losses caused by illegal cigarette market, according to survey by Povaddo.

A new report has revealed that only 14% of Europeans are aware that the illegal tobacco market causes member states of the European Union to miss out on over 10 billion euros in revenue each year. Meanwhile, more than 65% of respondents believe that illicit tobacco is an EU-wide issue, with two-thirds of those surveyed supporting different policy approaches.


These are the results of a new survey commissioned by PMI and conducted by research firm Povaddo across 13 European countries. The results were released during a media event in Brussels on Thursday.


Two-thirds of over 13,000 European adults surveyed by the European Union believe their countries have problems with illegal tobacco and nicotine-containing products, according to an investigation.


The results also showed that while European citizens recognize the use and trade of illegal tobacco products as a significant threat to their safety, security, and public health, they are not fully aware of the true extent of the illegal trade and its impact on national revenue loss.


According to a survey, 67% of respondents have reported that anti-smoking policies are being impacted by illegal activity. They believe that the growing illegal market is preventing many smokers from quitting or from switching to more expensive new nicotine products.


It is said that pragmatic thinking and common sense are needed to benefit all citizens in Europe and achieve positive change quickly. The survey results emphasize the demand of the public for "wise" tax methods based on risk and evidence, in order to:


Playing a role in encouraging citizens to make better lifestyle choices (66%). Motivating industries to develop innovative products that benefit consumers, reduce environmental impact, and contribute to sustainable development (73%). Encouraging interested adult smokers to switch to scientifically proven smoke-free alternatives, through taxation at a lower rate than cigarettes, but still high enough to prevent use by young people or non-smokers (69%).


Additionally, 60% of the population believes that government approval of innovative tobacco products will have a positive impact on smokers - who, on average, have lower wealth and knowledge levels - and in many EU countries, smokers represent a significant proportion of the smoking population. They should be treated equally with other Europeans who have quit smoking or chosen new products with more privileges.


Grégoire Verdeaux, Senior Vice President of PMI responsible for external affairs, spoke at an event, stating: "We are aware of the potential for doing better for adult smokers, as several member countries have already done in energy, automobiles, and alcohol. Pragmatic policies have the ability to improve people's lives, encourage companies to innovate better, and provide equal opportunities to access technological advancements, especially during times of economic instability.


William Stewart, President and Founder of Povaddo Research, expressed a hope that these findings will encourage the European Union and national authorities to take some time to evaluate the results of current policies and consider alternative methods.


He suggested that this could be achieved through "reasonable regulation and taxation while creating an environment that promotes innovation.


Stuart stated that one of the objectives of the investigation is to "evaluate the perceptions and attitudes of Europeans towards policies aimed at addressing illegal tobacco consumption, adult smoking, and measures aimed at helping them quit smoking or switch to healthier alternatives.


He highlighted that this investigation also aims to focus on whether adult smokers are receiving the correct support, "given the current inflation and economic uncertainty in Europe.


According to the survey respondents, the development of smokeless technology should be able to drive progress and play an important role in public health, supplementing existing measures.


61% of respondents believe that in addition to encouraging complete cessation of dangerous behavior, the EU should prioritize policies and strategies aimed at improving the lives of those who continue to smoke, drink irresponsibly or use drugs.


69% believe that innovation, technological breakthroughs, and science have played a role in reducing smoking rates.


Nearly three-quarters (72%) of people agree that the European Union should invest time and resources into eradicating smoking, encouraging all smokers to quit, or for those who don't quit, switch to scientifically proven smoke-free alternatives.


According to media reports, an increasing number of countries are implementing risk-based regulation, which is "encouraging" as it can play a "decisive role in encouraging consumers to adopt better alternative options without giving up, and pushing companies to invest in innovation.


It is worth noting that cigarettes are one of the most commonly trafficked illegal goods in the world, and can be categorized into three main categories: smuggled products, counterfeit products, and illegal “white” cigarettes.


In November 10-15, Povaddo conducted an online survey of 13,630 legally aged adults aged 18 and older in 13 EU member states: Belgium, Bulgaria, Croatia, the Czech Republic, France, Greece, Italy, Lithuania, Poland, Portugal, Romania, Slovakia and Spain. Approximately 1,000 online interviews were conducted in each country/region (roughly evenly distributed between adults who use and do not use nicotine-containing products).


Statement:


This article is based on machine-translated editing of third-party information, intended for industry exchange and learning.


This article does not represent the views of 2FIRSTS and we cannot confirm the authenticity or accuracy of the article's contents. The translation of this article is intended solely for industry exchange and research purposes.


Due to limitations in the compiler's ability, the translated article may not fully express the same meaning as the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong, Macao, Taiwan, and international issues and positions.


The copyright of the compiled information belongs to the original media and author, and if there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate
Former ATF Official’s Claims on Chinese Vape Companies and 6-Methyl Nicotine Fuel US Regulatory Debate
Former ATF Deputy Director Edgar Domenech has warned that some Chinese vape companies may be using 6-methyl nicotine, a nicotine analogue, raising new questions over how US regulators should classify emerging nicotine compounds.
Jul.13
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
China-based China Tobacco Hubei Industrial Co., Ltd. has filed a patent application covering an oral nicotine product and its preparation method. The patent proposes a soft candy-shaped oral nicotine product containing nicotine ingredients, gelling agents, sweeteners and alkaline pH regulators. Through formulation adjustments and homogeneous or dual-layer structures, the technology aims to achieve different nicotine release profiles. The filing reflects exploration of new oral nicotine product formats and controlled nicotine delivery approaches.
Aug.06
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
A new Virginia law that took effect on July 1, 2026, requires retailers to obtain permits to sell liquid nicotine, vape and tobacco products, while directing Virginia ABC to conduct inspections and verify that stores sell only products listed in the state directory.
Jul.20
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives